GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

TYRA-200   Click here for help

GtoPdb Ligand ID: 14207

Synonyms: example 181 [WO2022182972]
Compound class: Synthetic organic
Comment: TYRA-200 is a covalent FGFR inhibitor. It's chemical structure was disclosed during the First Disclosures session at the ACS Fall 2025 meeting. This same structure is claimed as example 181 in patent WO2022182972A1 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 3
Rotatable bonds 8
Topological polar surface area 104.92
Molecular weight 449.48
XLogP 1.58
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=CC(=O)NC1=CC2=C(C=C1)N(C=C2C)C3=C(C=NC(=N3)NC4=CN(CC(C)(C)O)N=C4)F
Isomeric SMILES CC1=CN(C2=C1C=C(NC(=O)C=C)C=C2)C3=C(F)C=NC(NC4=CN(CC(C)(C)O)N=C4)=N3
InChI InChI=1S/C23H24FN7O2/c1-5-20(32)27-15-6-7-19-17(8-15)14(2)11-31(19)21-18(24)10-25-22(29-21)28-16-9-26-30(12-16)13-23(3,4)33/h5-12,33H,1,13H2,2-4H3,(H,27,32)(H,25,28,29)
InChI Key IMSVRBNZOZXJLS-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
Patent WO2022182972A1 bins TYRA-200 affinities (Kd) for all 4 FGFR isoforms in the 0.1-100 nM range [1]. In cellular assays TYRA-200 demonstrated potent killing of cancer cells expressing FGFR2 or -3.
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
fibroblast growth factor receptor 1 Hs Inhibitor Inhibition 7.0 – 10.0 pKd - 1
pKd 7.0 – 10.0 (Kd 1x10-7 – 1x10-10 M) [1]
fibroblast growth factor receptor 2 Hs Inhibitor Inhibition 7.0 – 10.0 pKd - 1
pKd 7.0 – 10.0 (Kd 1x10-7 – 1x10-10 M) [1]
fibroblast growth factor receptor 3 Hs Inhibitor Inhibition 7.0 – 10.0 pKd - 1
pKd 7.0 – 10.0 (Kd 1x10-7 – 1x10-10 M) [1]
fibroblast growth factor receptor 4 Hs Inhibitor Inhibition 7.0 – 10.0 pKd - 1
pKd 7.0 – 10.0 (Kd 1x10-7 – 1x10-10 M) [1]